EIisa –a connected, affordable light solution for treating sleep apnea.broad
SUNRISE Tx · Horizon Europe grant · 2022-07-01–2024-12-31
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2021-ACCELERATOROPEN-01 · scheme HORIZON-EIC-ACC-BF · topic HORIZON-EIC-2021-ACCELERATOROPEN-01. CORDIS record →
Objective
Sunrise is a leading researcher and developer of solutions for diagnosis and treatment of sleep apnea. Our goal is to develop and commercialise Sunrise Tx, the first truly non-invasive, affordable and readily accessible solution to treat sleep apnea. This is to address the 80% treatment gap of sleep apnea sufferers who fail to access treatment due to high costs and long waiting times for diagnosis. Also, even within those diagnosed, at least 35% fail to comply with wearing a mask all night strapped tightly to the face, blowing air to clear airways for breathing due to the associated discomfort. In contrast Sunrise Tx is a wearable device involving no nasal obstruction. Sunrise Tx is set to improve treatment access, compliance, cost and accuracy.
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| SUNRISE | BE | coordinator | €1,939,875 | Yes |
Get the DFM funding briefing — free
New EU defence calls, tenders and awards in your inbox.
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; payment and subscription happen on DFM Analysis.